Loblaw stock rises 1.57% from latest report to 45.30 euros
Published on 11/04/2026 at 17:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for investors
- Loblaw stock traded above the level quoted in the latest same-day report.
- Loblaw's investor page presents its 2026 second-quarter release, report and supplementary slides as key company materials.
- The latest market move does not by itself establish a change in Loblaw's operating outlook.
Loblaw stock traded at 45.30 euros on Lang & Schwarz at 17:06 CET on Wednesday, November 4, 2026, 1.57 percent above the 44.60-euro level quoted in the latest same-day report at 13:39 CET. The move gives investors a fresh market marker, but it does not on its own establish a change in the company's operating outlook.
Quarterly materials remain the anchor
Loblaw's investor overview identifies the second quarter of 2026 as the 12 weeks ended June 20, 2026. The page provides the related news release, financial report and supplementary slides, giving shareholders the company's established reference point for sales, margins and earnings.
The latest share-price move is best read as a market signal rather than as proof of a new operating development. For the investment case, the next assessment remains whether Loblaw can turn its retail and pharmacy platform into sustained earnings progress.
Investors can follow the real-time quote of Loblaw stock.
Loblaw Companies Limited
- ISIN: CA5394811015
- Latest quote: 45.30 euros on Lang & Schwarz, Wednesday, November 4, 2026, at 17:06 CET
- Change since latest report: 1.57 percent above 44.60 euros quoted at 13:39 CET on November 4, 2026
- Reporting reference: Second quarter of 2026, 12 weeks ended June 20, 2026
The S&P/TSX Composite provides the relevant Canadian market backdrop for Loblaw investors through current Canadian market coverage.
